Haibin Yang
Hua Medicine (China)(CN)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Pancreatic and Hepatic Oncology Research, Lung Cancer Treatments and Mutations, Angiogenesis and VEGF in Cancer, Esophageal Cancer Research and Treatment
Most-Cited Works
- → Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy(2014)151 cited
- → Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplification(2017)5 cited
- → Abstract A118: Discovery of HMPL-A251, a first-in-class HER2-directed antibody-targeted therapy conjugate (ATTC) with a novel PI3K/PIKK inhibitor payload(2025)
- → Abstract 1890: HMA800067, a novel CD38-targeting antibody-drug conjugate (ADC), demonstrated superior anti-tumor activity to daratumumab in preclinical B-cell malignancies models(2024)